Literature DB >> 15639735

Acidosis of severe falciparum malaria: heading for a shock?

Kathryn Maitland1, Charles R J C Newton.   

Abstract

Severe Plasmodium falciparum malaria encompasses a complex syndrome affecting many organs and causing physiological perturbations that have many features in common with children with sepsis. Among these, metabolic acidosis has emerged as a central feature of severe malaria and is the best independent predictor of a fatal outcome in both adults and children. There is now clear evidence that intravascular hypovolaemia (shock) is common in children with malarial acidosis. How it should be treated presents a therapeutic dilemma because acidosis often coexists with impaired consciousness (cerebral malaria). We summarize the results of recent clinical trials examining the safety and efficacy of volume expansion in children with 'cerebral malaria' complicated by acidosis.

Entities:  

Mesh:

Year:  2005        PMID: 15639735     DOI: 10.1016/j.pt.2004.10.010

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  25 in total

1.  Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.

Authors:  Jin Guo; Armand W Guiguemde; Annael Bentura-Marciano; Julie Clark; Richard K Haynes; Wing-Chi Chan; Ho-Ning Wong; Nicholas H Hunt; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

Review 2.  Management of severe malaria in children: proposed guidelines for the United Kingdom.

Authors:  Kathryn Maitland; Simon Nadel; Andrew J Pollard; Thomas N Williams; Charles R J C Newton; Michael Levin
Journal:  BMJ       Date:  2005-08-06

Review 3.  Malaria: fluid therapy in severe disease.

Authors:  Susanne Helena Hodgson; Brian John Angus
Journal:  BMJ Clin Evid       Date:  2016-01-22

4.  Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity.

Authors:  Sergine Zougbédé; Florence Miller; Philippe Ravassard; Angelita Rebollo; Liliane Cicéron; Pierre-Olivier Couraud; Dominique Mazier; Alicia Moreno
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-04       Impact factor: 6.200

Review 5.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

6.  Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.

Authors:  Pedro Cabrales; Graziela M Zanini; Diana Meays; John A Frangos; Leonardo J M Carvalho
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

7.  Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles.

Authors:  George M Warimwe; Gregory Fegan; Jennifer N Musyoki; Charles R J C Newton; Michael Opiyo; George Githinji; Cheryl Andisi; Francis Menza; Barnes Kitsao; Kevin Marsh; Peter C Bull
Journal:  Sci Transl Med       Date:  2012-04-11       Impact factor: 17.956

8.  A high-content phenotypic screen reveals the disruptive potency of quinacrine and 3',4'-dichlorobenzamil on the digestive vacuole of Plasmodium falciparum.

Authors:  Yan Quan Lee; Amanda S P Goh; Jun Hong Ch'ng; François H Nosten; Peter Rainer Preiser; Shazib Pervaiz; Sanjiv Kumar Yadav; Kevin S W Tan
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

9.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

10.  Identifying prognostic factors of severe metabolic acidosis and uraemia in African children with severe falciparum malaria: a secondary analysis of a randomized trial.

Authors:  Eric O Ohuma; Mavuto Mukaka; Grace Mzumara; Stije Leopold; Kevin Marsh; Arjen Dondorp
Journal:  Malar J       Date:  2021-06-25       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.